The biopharmaceutical corporation Shire has announced a voluntary recall of six lots of Daytrana, a medication patch used to treat ADHD. According to a Dec. 3 article in the Philadelphia Business Journal, Shire says the recall is not a safety issue, but a functional one:

The company said patients and caregivers could have difficulty removing the liners. Some Daytrana patches do not meet or in the future may not meet their release liner removal specification, the company said.

The company stressed the action is not due to safety issues. "All Daytrana patches can continue to be used unless the release liner cannot be removed or the patches are damaged while being opened," Shire officials said.

In a Dec. 7 article on the website bnet.com, journalist and drug marketing expert Jim Edwards wrote that the latest recall should prompt Shire to end production of Daytrana:

This is the eighth recall of the Daytrana patch, a product on which Shires manufacturer, Noven, makes no profit because recall costs far exceed the revenues it gets from selling the thing, according to Novens most recent 10-Q. Daytranas marketing is already under investigation by the feds.

Its time to say it out loud: The Daytrana ADHD patch does not work, never has done, and should be quietly ditched by Shire and Noven before the FDA wakes up.

Labels: medications, patch, recall

Posted By: Aspen/CRC 0 Comments

Barr Laboratories, Inc. has initiated a recall of ADHD medication that it says may exceed weight requirements and could cause an over-dose if taken. The pills come from lot number 311756, the only lot affected by the recall.

An Aug. 14 Kentucky Post provided the following details about the recall:

Barr Laboratories, Inc. is initiating a voluntary recall of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a Single Entity Amphetamine Product) 20mg Tablets, 100 count bottles, lot number 311756.

The product identified is being recalled because the affected lot may contain some tablets exceeding weight requirements which may lead to super-potent tablets.

This product can be uniquely identified as an oval peach colored tablet, debossed with b/973 on one side and 2/0 on the other side. Barr distributed the affected lot between 06/11/09 and06/16/09. ... Customers who have this lot in their possession are instructed to cease using the product and return it to their pharmacy/distributor.

An overdose of this medication can lead to cardiovascular, neurologic, psychiatric and gastrointestinal reactions, the Post reported, though Barr Laboratories has not yet received notification of any adverse affects for this product lot.

For more information about this recall, call 888-742-5578 (Mondays to Fridays, 8 a.m to 8 p.m. EDT).

Labels: medications, recall

Posted By: Aspen/CRC 0 Comments